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lp9461 Oxidoreductive potential of cerebrospinal fluid 
(CSF) in patients with ticke-borne encephalitis 
W E )  
S. Pancewicz', A. Witek', M. Makarewicz', T. Hermanowska- 
Szpakowicz', M. Kondrusik'. 'Department of Parasitic Diseases and 
Neuroinfctions, 'Departnient qf Analytical Chemi.stry, Medical University, 
Bialystok, Poland 
Objectives: Evaluation of the oxidoreductive potential of CSF in 
patients with TBE. 
Methods: 14 patients aged 21-64 were analyzed. The diagnosis 
was based on the detection of IgM antibodies against theTBE virus 
or IgG increase by ELISA test (FSME IgM, IgG, IMMUNO). In 
cerebrospinal fluid (CSF) the following were measured the activity 
of superoxide dismutase (SOD), glutathione peroxidase (GSH-Px), 
glutathione reductase (GSSG-R), thiobarbituric acid-reactive 
substance (TBAKS) and -SH Igroups. The control group consisted of 
10 patients whose CSF parameters remained within the normal 
range. The CSF examination was performed twice, before and after 
treatment. The results were statistically analyzed by ANSTAT. 
Results: Analyzed activities of SOD, GSH-Px, GSSG-R and -SH 
were significantly lower compared with the control group in both 
exaininationc. Only TBARS was higher in both examinations. 
Comparison of obtained results between examinations 1 and 2 
showed a decrease in GSS-R and TBARS after treatment. 
Conclusions: The inflammatory process which develops in 
meninges during TBE causes the molecular structure injury of 
enzymes and antioxidative reactive co-factors 
1- Peptic ulcer in childhood: what is the 
pathogenetic role for Helicobacter pylori 
urease? 
A. Nijevitch, V Sataev, P Mimnov, R. Khasanov, N. Kazykhanov. 
Outpatient Departnzent, Cbiildren 'r Republican Hospital, Uja. Russia 
Objectives: Investigation of the interrelation between peptic ulcer 
formation in  childhood (purst unifactorial model) and intragastric 
urease activity associated with Helicobacter pylori infection 
Methods: We investigated 80 consecutive pediatric outpatients 
(30 males) 4-15 years old (mean age 11.3 years) infected with 
Helicobarter pylori. Ulcer craters were detected at endoscopy in 15 
children. The presence of H. pylori was confirmed by IgG serology, 
histology and polymerase chain reaction. In all patients we took one 
supplemental biopsy sample of gastric mucosa for urease activity 
measurement and inoculated it into 'De-No1 test' broth (Yanianouchi 
Europe, The Netherlands). Extinction at 540 nm was measured with 
a photometer (Asa junior, Coultronics, France) at 4 h. Urease activ- 
ity was expressed as units of optical density/mg biopsy tissue/h. We 
multiplied the data obtained by 1000. 
Results: In children with ulcers the mean value of urease activity 
was not significantly different from the mean2SD urease activity in 
children with H. pylori-related chronic gastritis without ulcer 
(54.3k10.2 versus 4 4 . 7 t  16.4 OD units/mg biopsy tissue/h, p 0.05). 
After a 4-week course of ranitidine, all the ulcers were healed, but 
the difference between initial urease activity level and its mean value 
after treatment (46.4f 14.8 O D  units/mg biopsy tissue/h) was also 
not significant (p 0.05). 
Conclusions: H. pylori-asociated intragastric urease activity is 
likely much more predictive (of H. pylori colonization than of ulcer 
disease origin. 
Impact of iron loading on murine tuberculosis 
N. Lounis', C. Maslo', l? Bonnafous', C. Truffot-Pernot', J. 
Boelaert', B. Ji'. J. Grosset'. 'Facrrltl de MCdrrine, Piirii-Salp&ri+?re. 
Paris, Franre; 'A .Z.  St+~n, Bnrgye, Bekiuni 
Objectives: To demonstrate in a mouse model of tuberculosis that 
excess iron load is increasing the multiplication of Mytobncteriunz tuber- 
culosis. 
Methods: Eighty-nine female BALB/c mice aged 6 weeks were 
infected intravenously with 5.4X lo4 CFU per mouse. Before infec- 
tion, 46 of them were treated for 2 weeks with 50 nig/kg polymal- 
tose ferric hydroxide, a source of iron. To monitor the growth of M.  
tuberculosis in mice, 15, 13 and 12 control mice and 15, 13 and 17 
iron-treated mice were sacrificed the day after infection ( i l l ) ,  and on 
day 14 (D14) and day (D28) after infection. At each \acrifice, mice 
and their spleens are weighed, lung lesions are noted, and the number 
of M. tirberculosis CFU determined by quantitative cultures of vpleen 
and lungs. 
Results: O n  day 1, there was no significant difference between 
the mean numbers of CFU in the control and the iron-treated mice 
in both spleens and lungs (p 0.05). O n  days 14 and 28 after infection, 
the number of CFU was significantly higher in the spleens of iron- 
treated mice than in control mice (P=0.004 for D14 and P=O.OOO 
for D28). 
Conclusions: Iron loading of BALB/c mice significantly 
enhances the multiplication of M .  tubrrculoris in the spleens. 
Animal models 
wl Role of inflammation in antibiotic efficacy in 
Streptococcus pneumoniae (Sp) andlor 
HemopMus influenzae (Hi) otitis media (OM): a 
pharmacodynamic gerbil model 
F. Soriano', A. Parra', C. Cenjo?, E. Nieto', G. Garcia-Calvo', 
M.J. GimPnez', L. Aguilar', C. Ponte'. Departmenrs of 'Microbiology 
and 'Otolaryngolo'qx FundacionJimCnez Dim, 'SmirhKIine Beerkam 
Pbarm, Madrid, Spain 
Objectives: To compare the efhcacy of co-amoxiclav (A/C) v e r w  
cefuroxime (CXM) in an O M  model caused by Sp (MICAK:=I 
pg/mL; MICcx~=4pg/mL)  plus non-typeable HI (MICAK.=C:XM= 
1 pg/niL) in mixed inoculum versus single Hi inoculum. 
Methods: Middle ear (ME) infection was induced in gerbils (I5 
animals/group) by bilateral transbulbar challenge with 5 X 10" CFU 
Sp and/or 5x10'  CFU Hi  per ear. Antibiotic treatment (sbc) was 
started 2 h post-inoculation and continued every 8 h up to three 
doses. Infection status was checked 2 days later by counting the bacte- 
ria in ME. ME antibiotic concentrations were determined YO min 
after an sbc 5 nig/kg dose administered 46 h post-bacterial inocula- 
tion. 
Results: Percentage of ME sample5 with the stated culture 
results: 
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ME levels (pg/mL) increased from 0.9 in the single model to 2.4 
in the mixed model for A/C and from 0.8 to 2.2 for CXM. 
Conclusions: A/C high dose was the only regimen that obtained 
similar efficacy (90%in both models). The presence of Sp increased 
ME antibiotic levels, increasing Hi eradication rates. 
I P950 I Amoxycillin treatment by reproducing human 
pharmacokinetics of penicillin-resistant and 
penicillin-susceptible Streptococcus 
pneumoniae experimental pneumonia in 
immunocompetent rabbits 
L. Piroth, A. Coulon, L. Martin, C. Lequeu, M. Duong, M. 
Buisson, H. Portier, P. Chavanet. Infectious Diseases Department, 
CHL’ D i m ,  France 
We developed a new model of pneumonia in immunocompetent 
rabbits, due to 1 penicillin-susceptible (PSSP) as well as 2 penicillin- 
resistant strains (PRSP, MIC=4 nig/L) of Streptococcus pneumoniae 
(SP) in order to evaluate the efficacy of amoxycillin. Two groups of 
rabbits were inoculated into bronchi, with either PSSP (n=17) or 
PRSP (n=17). In each group, 7 rabbits were not treated (nt); mean- 
while, the equivalent of human 1 g of amoxycillin by oral (PO, n=5) 
or intravenous (IV, n=5) route was simulated in rabbits by computer- 
controlled infusion, for 5 administrations 8 h apart. Rabbit plasma 
levels obtained were very close to human ones following oral or IV 
amoxycillin administration. All treated or untreated rabbits were 
killed 48 h after inoculation. 
Lung pathologic scoring and microbiological evaluation (log 
CFU/g) were done. Results were as follows. 1-PSSP model: la-lung 
pathologic score: nt=2.45+0.88, P0=3.64?0.88, IVz2.91 k0.77; 
lb-lung SP content: n t=5.78?0.63, PO=1, IV=1; lc-spleen SP 
content: n ~ 4 . 5 4 k 2 . 2 4 ,  P O = l ,  IV=l .  2-PRSP model: 2a-lung 
pathologic score: nt =2.69+ 1.04, PO = 2.46k 1.16, IV= 2.34 k 0.08; 
2b-lung SP content: nt=4.15+1.98, P0=1.21+0.42, IV=1.44? 
0.81; 2c-spleen SP content: n ~ 4 . 1 8 k 2 . 2 3 ,  PO=1, IV=1. 
Histopathologic lung lesions were not different between treated and 
untreated rabbits infected by PSSP or PRSP. SP concentrations in 
lung and spleen were significantly lower in treated rabbits for PSSP 
(p<0.0001 andpc0.005, Dunnett’s test) and also PRSP (p<0.01 and 
p<0.05, Dunnett’s test). Lung and spleen SP concentrations were not 
different between treated groups irrespective of administration route 
(oral versus IV) and or type of strains (PSSP versus PRSP). These 
results suggest that amoxycillin 1 g t i d .  given by the oral or IV route 
is sufficient to obtain significant SP clearance in immunocompetent 
individuals with pneumonia, even with PRSP with MIC=4 mg/L. 
m1 Group B streptococcal beta-hemolysin induces 
nitric oxide production in murine macrophages 
and death and multiorgan failure in rabbits 
A. Ring, V. Nizet, W. Stremmel, J.L. Shenep. Internal Medicine IC: 
University o j  HeidelbeT, Heidelbeg, Germany 
Although the incidence of Gram-positive sepsis is increasing, current 
knowledge of the Gram-positive bacterial virulence factors respon- 
sible for septic shock is sketchy. In this study, we investigated the role 
of cytotoxic beta-hemolysin expressed by group B streptococcus 
(GBS) for the expression of inducible nitric oxide syntbase (iNOS) 
and NO release from murine macrophages (RAW 264.7) in vitro and 
in rabbits in vivo. Hemolysin-producing clinical isolates of GBS tran- 
scriptionally induced the expression of iNOS protein in RAW cells 
in a dose- and time-dependent manner. Isogenic non-hemolytic 
(NH) GBS mutants were less potent inducers of NO release (4-fold) 
and iNOS protein expression than their wild-type (WT) counter- 
parts. Hyperhemolytic(HH) mutants were more potent than W T  at 
lower concentrations. GBS-mediated induction of iNOS was 
inhibitable by antagonists of protein tyrosine kinases and NF-kappa- 
€3 but not by antagonists of protein kmases A and C. In particular, 
the specific Src family and p38 kinase but not the ERK1/2 @42/44) 
kinase antagonists were effective inhibitors of GBS-activated NO 
release from RAW cells. 
Intravenous challenge of rabbits with HH mutants resulted in 
significantly higher mortality compared to WT or N H  mutants 
( n = l l ,  64%, 37% and 18%, respectively). Histologic examination 
revealed organ damage exclusively in HH-treated animals. It was 
most prominent in the liver, with less injury seen in kidney, heart, 
muscle and lung. 
We conclude from our results that GBS beta-hemolysin may be 
crucial to the pathogenesis and mortality of GBS septic shock by its 
ability to induce iNOS in macrophages and possibly by direct 
hemolysin-mediated injury to organs. 
In vivo synergy between ampicillin (A) and 
gentamicin (GI in experimental endocarditis 
due to E. faecium (EF) with resistance to 
ampicillin 
P. Lopez, N. Borrell, C. Torres, B. Almirante, C. Tenorio, J.A. 
Capdevila, J. Maristany, J. Gomis, F. Baquero, J. Gavalda, A. 
Pahissa. Infectious Diseases Research LAboratoq Hospital Rail Hebron, 
Barcelona; Universidad de LA Rioja, Logrorio, Spain 
Objectives: To date, the ‘gold standard’ treatment of endocarditis 
due to these strains has been vancomycin (V) plus G. The aim of this 
study was to evaluate in vitro synergistic activity and in vivo efficacy 
of A+G in the treatment of experimental endocarditis in rabbits due 
to strains of EF with resistance to A. 
Methods: MICs to A, G and V and synergistic activity between 
A and G by time kill curves were studied in five strains of EF with 
MIC ranges of 16-32 mg/L of A and 32-64 mg/L of P. In vitro 
bactericidal synergy was obtained in four strains when A concentra- 
tions used were in the range of 1 /2 to 2 times the MIC of A. In vivo 
experiments were done as follows: 24 h after induction of non- 
thrombotic aortic valve endocarditis, 10’ CFU of EF-334 (MICs to 
A, G and V 32, 4 and 0.5 mg/L respectively) were inoculated into 
rabbits. 24 h later, animals were treated with A (2 g/4 h), A (2 g/4 
h)+G (1.5 mg/kg/8 h), and V (1 g/12 h)+G (1.5 mg/kg/8 h) by 
using human-like pharmacokinetics. Animals were sacrificed 6 h after 
the end of 3 days of treatment. 
Results: Results expressed as mean logto CFU/g vegetation (95% 
CI of mean) for each treatment group were: C 7.2 (5.6-8.54); A 6.9 
(5.6-8.5); A+G 4.3 (2.M.59); V+G 3.5 (2.0-4.86) (pc0.05 versus 
A and controls). 
Conclusions: The treatment of endocarditis due to EF with resis- 
tance to A is V plus G. The combination A+G may be an alterna- 
tive effective treatment. 
Treatment of experimental Staphylococcus 
aureus (SA) catheter-related infection (CRI) 
using the antibiotic-lock technique (ALT) 
J.A. Capdevila, J. Gavaldh, P. L6pez, N. Borrell, J. Fortea, A. 
Pahissa. Hospitals Kll d Hebrbn, Barcelona, Spain 
Objectives: CRI could be treated successfully without catheter 
removal. However, controversies exist about what is the most active 
antibacterial agent. To evaluate the efficacy of rifampin (R) in the 
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treatment of S.aureur CRI using the ALT, we evaluated the in vivo 
activity of R alone or in combination with vancomycin (V) or 
ciprofloxacin (C) in the Rx of an animal model of CRI.  Also, we 
checked for the possible appearance of resistance to R during Rx. 
Methods: New Zealand rabbits were surgically implanted with a 
silicone catheter (Vygon) through the right jugular vein. After inser- 
tion, the catheter was locked with the broth culture containing loH 
CFU/mL of N. 16.2 SA. 18 h later, ALT was started. Treatment 
groups were: (1) Control; (2) R. 3000 pg/mL; (3) V 3000 pg/mL; (4) 
C 2000 pg/mL; (5) R+V; (6) R+C. 24 h later, the catheters were 
microbiologically evaluated. R-esults were expressed in log of CFU 
(ineank SD). 
Results: Rollplate (+,'total) Fluslung Sonication 
Control 13/13 4.63f1.03. 4.57rl 12. 
R 3/Mb 1.54HJ.82 1.63f1.05 
V Ill1 I 4.6OH.87 4 92f 0 92 
C 7/111 2.83f1.53 2.61*1.7? 
R+V 3 1  1- 1.75HJ.74' 164?3.71 
R+C 0113' 1 54HJ.66' 1.23iO 76' 
Chi-square+ and Mann-Whitney': p<0.05 versus control group and 
V. One strain recovered from the R group showed rifampin resis- 
tance: MIC=R pg/mL. 
Conclusion: Rifampin has good antibacterial activity against SA 
in an animal model of CRI. Concern exists about the appearance of 
resistant strains 
Efficacy of imipenem, sulbactam, colistin, and 
amikacin in experimental endocarditis caused 
by Acinetobactea baumannii with intermediate 
susceptibility to imipenem 
L. Cuberos, M.J. Rodriguez-Hernandez, C. Pichardo, EJ. 
Caballero, I. Moreno, B. Becerril, M. Bernabeu, J. Pachon Diaz 
Seruicio de Enfermedades Irqecciosas, H. U. Vixen del Ron'o, Seuille, 
Spain 
Objectives: Acinetobacter baumannii may develop resistance to antimi- 
crobials, including resistance to iinipenem. The objective of this work 
was to determine the efficacy of other antimicrobials using a 
bacteremic model as experimental endocarditis 
Materials and methods: We have evaluated the efficacy of 
imipenem (IMP), sulbactam (SB), amikacin (AK), and colistin (CL). 
New Zealand rabbits were inoculated with n108 CFU of A .  bauman- 
nii (MIC of imipenem 8 pg/mL) susceptible to the other antimicro- 
bials. The rabbits received during 24 h no treatment (CON), IMP 
(60 mg/kg/t.i.d.), SB (30 mg./kg/t.i.d.), AK (15 mg/kg/q.d.), CL 
(5 mg/kg/b.i.d.). Quantitative blood and vegetation cultures were 
performed. Bactericidal activity was evaluated using a time-kill method 
with antimicrobial concentrations= C,,,, in rabbits. Statistical analy- 
sis: Fisher, ANOVA, and post-hoc Dunnett and Tukey tests. 
Results: IMP was the most active in the sterilization of vegeta- 
tions (63.6%, p<0.05), followed by SB and CL (44.4% and 40% 
respectively). Only IMP showed differences kom the C O N  group in 
the clearance of A .  baumannii from vegetations (2.9k1.7 versus 
6.3-C 1.8 CFU/g, p<0.05). With respect to the sterilization of blood 
cultures, only CL increased the number compared with the C O N  
group (80% versus 0%, p<0.05). However, in the quantitative blood 
cultures, IMP (1.320.4 CFU/inL), SB (1.5k0.7 CFU/mL), and CL 
(1.3?0.8 CFU/mL) showed differences from the CON group 
(2.720.9 CFU/niL, p<O.05). 
Conclusions: Imipenem was the most active antimicrobial, in 
spite of the diminished in vitro susceptibility against A .  baumannii. 
Although sulbactam and colistin were efficacious in the clearance of 
A .  balrrnannii from blood, they were ineffective in the treatment of 
endocarditis. 
lp955] Experimental pneumonia and endocarditis due 
to Acinetobacter baumannii. Efficacy of 
monotherapy with imipenem versus 
combination therapy of imipenem plus 
amikacin 
C. Pichardo, L. Cuberos, M.J. Rodriguez-Hernandez, EJ. 
Caballero, 1. Moreno, B. Becerril, A. Garcia-Curiel, J. Pachon 
Diaz. Seruicio de Enfermedades Infcciosas, H .  U. Viyen del Rocio, 
Seville, Spain 
Objectives: To determine if amikacin plus imipenem iniprovec the 
efficacy of imipenem therapy using murine experimental pneunio- 
nia and rabbit experimental endocarditis models due to Acinetobacter 
baurnannii. 
Materials and methods: MIC, MBC, time-kill curves, and 
synergy of imipenem plus amikacin were studied. In the experimen- 
tal pneumonia, C57BL/6 mice and an inoculum of 50 mL ( x l O H  
CFU/mL) were used. In the experimental endocarditis, New 
Zealand rabbits and an inoculum of 1 mL ())lox CFU/niL) were used. 
In both models, four treatment groups, for 72 h and 24 h respec- 
tively, were evaluated: control, imipenem, amikacin, and imipenenl 
plus amikacin. Statistical analysis: Fisher, ANOVA, and post-hoc 
Dunnett tests 
Results: Iniipenem plus amikacin showed in vitro synergy against 
the A .  baumannii strain used in the pneumonia model. In the control 
group the mean log CFU/g oflung was 10.3k0.4 and mortality was 
100%. All treatment groups had improved survival (p<0.05). 
Monotherapy with imipenem was as effective as imipenem plus 
amikacin in bacterial lung clearance (1.521.4 versus 2.421.4 
CFU/g) and in lung sterilization (55.5% versus 33%)). In experi- 
mental endocarditis the control group had a mean log CFU/g of 
vegetation of 6.321.8. The imipenem monotherapy group had 
improved bacterial vegetation clearance (2.95 1.7, p<0.01) and vege- 
tation cterilization (63.3% versus 0%) in conti-ol group, p<0.05). 
Imipenem plus amikacin does not improve the results of imipenem 
monotherapy in endocarditis. 
Conclusions: These results suggest that in the treatment of severe 
infections caused by A .  baumannii, monotherapy with imipenem is 
efficacious and that the association with an aminoglycoside is not 
necessary. 
lp956] Efficacy of moxifloxacin (BAY 12-8039) in the 
treatment of experimental legionnaires' 
disease 
M.S. Lever', A. Williams,' A.C. Davies, G.A. Hall', A. Dalhoff. 
'CAMR, Porton Down, Salisbury, VK; 'Bayer AC, Wuppertal, 
Germany 
Objectives: To investigate the efficacy and persistence of inoxi- 
floxacin in an alveolar macrophage assay and an aerosol infection 
guinea pig model of human legionnaires' disease. 
Methods: Animals were infected by the aerosol route with 5L11so 
L. przeumophila (1 O5 * CFU/lung). Moxifloxacin was administered 
subcutaneously at 1.0, 2.0 and 4.0 mg/kg for 7 days, commencing 
24 h post-infection (p i ) .  Tissues for bacteriology and histology were 
taken on days 1, 2, 3, 7 and 14 p.i. The persistence of moxifloxacin 
in serum and tissues was assessed for 6 h following a single 4 nig/kg 
dose. For the macrophage assay, animals were infected as above. At 5 
h p.i., alveolar macrophages were harvested and incubated in tisue 
culture containing moxifloxacin (0-lOpg/mL). Intracellular growth 
was determined by viable counts of disrupted macrophages after 0, 
24 and 48 h. 
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Results: The intracellular MIC in infected alveolar macrophages 
was 3.0 pg/mL after 24 h, rising to 10 g/mL after 48 h. Moxifloxacin 
treatment at 1.0, 2.0 and 4 mg/kg for 7 days pi .  prevented deaths 
and reduced viable bacteria in the lung,  compared with untreated 
controls. No remission of infection was evident 1 week after cessa- 
tion of treatment. After a single 4 mg/kg dose, serum levels of 2-4 
pg/mL were achieved for up to 6 h. Levels of moxifloxacin increased 
over 6 h in the lungs. Histology confirmed that treatment prevented 
dissemination of L. pneumophila to spleens of infected animals. 
Conclusions: The data suggest that moxifloxacin could be of 
value in the treatment of legionnaires‘ disease. 
wl Effect of pravastatin on Chlamydia 
pneumoniae infection 
L. Erkkila, K. Laitinen, M. Leinonen, P. Saikku. National Public 
Health Institute, Helsinki and Oulu, Finlaad 
Objectives: Statins may have other effects besides lowering serum 
lipids, Our aim was to study the possible effect of pravastatin on the 
growth of Chlamydia pneumoniae (Cpn), commonly found in athero- 
sclerotic lesions, in cell cultures. 
Methods: Cpn strain Kajaani 7 was used to inoculate Vero cells 
grown in 24-well plates. 3600 IFUs were used in duplicate. 
Pravastatin was used in final concentrations of 5, 10 or 20 mg/L. 
Pravastatin treatment started 1 day before the Cpn infection. Samples 
were collected daily, and cells were fixed and stained for inclusion 
counts. 
Results: Pravastatin seemed to have a weak positive effect on the 
uptake of chlamydia by the cells. Mean numbers of inclusions per 
slide 48 h after infection were 834, 1412, 1572 and 1640 in the wells 
treated with 0, 5, 10 and 20 mg/L ofpravastatin, respectively. A more 
significant difference was seen 72 h after infection, when the mean 
numbers were 928, 56, 67 and 1484 inclusions per slide in wells 
treated with 0, 5, 10 and 20 nig/L, respectively. 
Conclusions: Pravastarin Feems to have both enhancing and 
depressing dose-dependent effects on the growth of Cpn in Vero 
cells. Pravastatin promoted the uptake of chlamydia by the cells, but 
it also helped the host cell to get rid of the chlamydia. Further stud- 
ies are needed to elucidate its effect on chronic Cpn infection (e.g. 
in animal models), which might be more important in the develop- 
ment of coronary heart disease. 
Im] Once-daily dosing optimizes effectiveness 
and decreases toxicity of daptomycin 
F.B. Oleson, Jr’, C.L. Berman’, J.B. Kirkpatrick’, K.S. Regan’, J-J. 
Lail, EI? Tally’. ‘Cubist Pharmaceuticals, Inc., Cambridge, MA, 
ZConsultant, Wayland, MA, ’ WIL Research Laboratories, Ashlund, 
OH, USA 
Daptomycin is a novel lipopeptide antibiotic with potent bacterici- 
dal activity against Gram-positive bacteria, including resistant strains. 
Leggett et al have shown previously in a mouse thigh infection model 
that effectiveness of daptomycin is optimized by once-daily dosing, 
since C,,,,, was found to be the key PK parameter associated with 
eradication of infection. Skeletal muscle has been identified as the 
target organ of dapromycin toxicity, To investigate the potential 
effects of dose fractionation on toxicity, two studies were conducted 
in dogs comparing the effects of repeated intravenous administration 
once daily (q24h) versus every 8 h (q8h). Muscle toxicity did not 
appear to be directly related to C,,,,,, since both serum CPK increases 
and the incidence of microscopic myopathy observed at 25 ing/kg 
q8h were greater than at 75 mg/kg q24h despite the lower C,,,,. A 
4-5-fold increase in CPK levels was observed at a constant dose of 
25 mg/kg administered at intervals of q8h versus q24h. whereas a 
negligible difference was apparent at a constant interval of 24 h at 
doses of 25 versus 75 mg/kg. Furthermore, 5 mg/kg administered 
q24h caused no change in CPK, whereas a dose regimen of q8h was 
associated with a 3-fold increase in CPK at a comparable C,,,. 
Siniilarly, toxicity was not related primarily to AUC24h, since the 
toxicity observed at 25 mg/kg q8h was greater than at 75 mg/kg 
q24h, at approximately the same AUC. The data suggest that dosing 
interval had a greater influence on toxicity than did dose itself. Once- 
daily administration is hypothesized to allow greater time between 
doses for repair of subclinical muscle damage associated with dapto- 
niycin. These results suggest that once-daily dosing can minimize 
daptoniycin muscle toxicity, while optimizing its antimicrobial efi- 
cacy. 
HIV-epidemiology, opportunistic infections II 
lp958] DNA and RNA PCR in the diagnosis of vertical 
transmission of HIV-1 
C. Munoz, A. Gonzalez-Cuevas, C. Fortuny T. Jnncosa, A. Gen6, 
C. Latorre. Hospital SantJoan de Deou, Barcelona, Spain 
Objectives: To evaluate the use of P C R  in the determination of 
DNA provirus and quantification of viremia in the vertical transmis- 
sion of HIV-1. 
Patients: All children born of anti-HIV-1-positive mothers 
uanuary 1995 to December 1997) and checked in our hospital. 
Methods: HIV Ab (Cobas Core, Roche), P24 Ag (Innotest HIV, 
Innogenetics) and DNA provirus of HIV-1 (Amplicor HIV-1, 
Roche) were tested at 0 (according to availability), I, 3 , 6, 12 and 
18 months. In infected patients, viral RNA was quantified (HIV-1 
monitor, Roche) retrospectively in the first diagnostic sample. 
Results: 104 incants were studied. Median age at first determina- 
tion was 81 days (range: 0 days to 22 months). Vertical transmission 
rate was 7.6% (8 infected patients). Sensitivities of P C R  and P24 Ag 
in the first determination were 100% and 50% and specificities were 
100% and 95.4%. Only one of the eight infected patients had received 
correct zidovudine prophylaxis, and only two of the mothers knew 
they were infected before delivery. The median plasma HIV-1 RNA 
at diagnosis was 1 405 176 copieslml (6.1 loglo) in the eight infants, 
and it was always at least 100 000 copies. 
Conclusions: Determination of DNA provirus is an excellent 
method for diagnosis of vertical transmission of HIV-1, offering the 
possibility of early intervention. The high viral load during the first 
years of life possibly reflects the fact that the infant immune system 
is less effective than the adult’s for viral infection control. 
[m Differences in economiclclinical outcomes of 
HIV care by ethnicity: a Ryan White experience 
M.K. Rawling;’, M. Pasleyl, C. de Guzman’, D. Lapins2. 
‘Southeast Dallas Health Center, Parkland Health G. Hospital System, 
Dallas, Exas, ’Clinial Partners, San Francisco, CA, USA 
Objectives: To determine any disproportion in 0 1  incidence rate 
(OIIR), hospital admissions and cost by ethnicity among HIV- 
infected individuals seen in the Community Oriented Primary Care 
Program at Parkland Health & Hospital System (PHHS) in Dallas, 
TX. 
